New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 21, 2014
09:19 EDTSRPTSarepta upgraded to Outperform from Market Perform at William Blair
William Blair upgraded Sarepta to Outperform after the company said it can file a new drug application for eteplirsen for the treatment of Duchenne muscular dystrophy by year end.
News For SRPT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for SRPT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use